Table 4. Duration and incidence of LRTI confirmed by paediatric physician.
|
PP analysis |
ITT analysis |
|||
|---|---|---|---|---|
| Placebo (N=29) | Active (N=28) | Placebo (N=33) | Active (N=33) | |
| Number of days | ||||
| Mean (s.d.), days | 1.0 (3.4) | 0.5 (1.8) | 0.9 (3.2) | 0.9 (3.5) |
| Mean difference (95% CI) | −0.6 (−2.0, 0.8) | 0.03 (−1.6, 1.6) | ||
| P-value | 0.425 | 0.970 | ||
| Incidence rate ratio (95% CI) | 0.5 (0.1, 2.8) | 1.0 (0.2, 4.0) | ||
| P-value | 0.447 | 0.989 | ||
Abbreviations: CI, confidence interval; ITT, intention to treat; LRTI, lower respiratory tract infection; PP, per protocol.